je.st
news
Tag: pfizer
FDA approves Pfizer drug to treat rare lung disease
2015-05-29 07:59:05| Biotech - Topix.net
The US Food and Drug Administration on Thursday approved the first drug to treat a rare, progressive lung disease that mainly affects women of childbearing age. WASHINGTON: The US Food and Drug Administration on Thursday approved the first drug to treat a rare, progressive lung disease that mainly affects women of childbearing age.
Would Pfizer Buying GlaxoSmithKline Make Sense?
2015-05-23 05:35:16| Biotech - Topix.net
The Pfizer conundrum What makes this outperformance so unique and strange is the fact that growth stocks are typically the most prominent outperformers during a bull market, while income plays and mature growth opportunities, such as Pfizer, often underperform the broad market. To make matters even more confusing, patent exclusivity losses have hit Pfizer hard.
Tags: make
sense
buying
pfizer
Pfizer Buys a Minority Stake in Dutch Biotech Firm AM-Pharma
2015-05-12 21:19:02| Biotech - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tags: firm
dutch
minority
biotech
23andMe, Pfizer jointly launch Lupus Research Study
2015-05-05 23:20:22| Biotech - Topix.net
The effort is also in collaboration with the Lupus Research Institute, and in concert with Lupus Awareness Month in May. Approximately 1.5 million people in the U.S. suffer from lupus, an autoimmune disease in which the immune system can attack the normal, healthy tissues of the body almost anywhere. Some of the more common symptoms include joint inflammation, skin rashes and sores, as well as kidney, heart, and lung damage.
Tags: research
study
launch
jointly
Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources
2015-04-30 19:21:27| Biotech - Topix.net
The Swedish company, known as Sobi, has a market value of 35.8 billion Swedish crowns . Its medicines for rare or "orphan" conditions make it a target in a consolidating sector in which large, cash-rich drugmakers seek to bolster their portfolios with offerings from smaller biotech firms.
Tags: sources
exclusive
disease
rare
Sites : [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] next »